• Allarity Therapeutics entered an amended and restated management services agreement effective June 1, 2026 with Ljungaskog Consulting AB, owned by CEO Thomas H. Jensen.
• 2026 base pay set at SEK 6 million paid 80% in Swedish krona, 20% in US dollars totaling USD 163,043; $100,000 signing bonus removed.
• Annual bonus capped at 60% of monthly fees paid in a calendar year; payout due by March 15 following year-end.
• Company termination for convenience now requires 30 days’ notice, triggers 12 months of monthly fees paid semi-monthly, subject to release and cooperation conditions.
• Good Reason exit also triggers 12 months of monthly fees, replacing a prior nine-month payment structure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allarity Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-064278), on June 02, 2026, and is solely responsible for the information contained therein.